News
July, video editor Meng Meng, 38, has been injecting herself with a weekly weight loss drug, hoping it will finally help her ...
Prices for Indian consumers are expected to come down significantly from the current Rs 17,000-Rs 26,000 monthly.
A new daily pill for obesity, orforglipron, has shown promising results in a major clinical trial, helping patients lose ...
Drugs such as Ozempic, Wegovy and Mounjaro (known as semaglutide and tirzepatide) have changed the way clinicians manage ...
More than one in five UK adults tried to access weight-loss medications in the past year alone, according to a survey by the National Pharmacy Association.
Overview As demand for GLP-1 drugs continues to skyrocket, federal and state agencies are turning their attention to the GLP-1 market and ramping up efforts to address the perceived risks associated ...
Detailed price information for Skye Bioscience Inc (SKYE-Q) from The Globe and Mail including charting and trades.
Obesity medicine specialist Sue Pedersen says the updates also focus on individualizing care and move away from relying on ...
A wide variety of unapproved FDA drugs were discovered during inspections, including nearly 55,000 fake injectables and pills ...
Novo Nordisk's FY 2025 guidance cuts are driven by softer U.S. Wegovy/Ozempic and GLP-1 trends. Click here to find out why I ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results